Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Recommendation of “Moderate Buy” by Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned an average recommendation of “Moderate Buy” from the twenty-one ratings firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $610.19.

Several research analysts recently commented on the company. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Bernstein Bank upped their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th.

Intuitive Surgical Price Performance

ISRG stock opened at $488.80 on Tuesday. The stock has a market capitalization of $174.10 billion, a P/E ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43. The business has a 50-day moving average of $566.38 and a 200-day moving average of $531.96. Intuitive Surgical has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently modified their holdings of the company. Norges Bank bought a new position in shares of Intuitive Surgical in the 4th quarter worth about $2,401,493,000. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical in the 3rd quarter valued at about $558,807,000. Proficio Capital Partners LLC increased its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC increased its position in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Finally, Capital Research Global Investors boosted its stake in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock valued at $1,764,904,000 after purchasing an additional 687,906 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.